Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Cell Genesys to evaluate new gene therapy for AIDS

April 12, 1996

DaunoXome approved as first-line treatment for KS

April 12, 1996

Expanded access for delavirdine initiated

April 12, 1996

ImmuCell arranges for clinical evaluation of CryptoGAM

April 5, 1996

DuPont Merck research into protease inhibitors

April 5, 1996

New data, new approvals for DaunoXome

April 5, 1996

New protease inhibitors from BMS

April 5, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Nitazoxanide advances in phase II

March 15, 1996

Neupogen approved for AIDS-related indication

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...